Fig. 3From: Overexpression of OCT-1 gene is a biomarker of adverse prognosis for diffuse large B-cell lymphoma (DLBCL): data from a retrospective cohort of 77 Brazilian patientsOverall survival (OS) in the intermediate-high and high-risk IPI subgroup according to OCT-1 gene expressionBack to article page